Fujifilm India has partnered with Bangalore-based multi-speciality private healthcare provider Sakra World Hospital to launch a new AI-enabled software assisting doctors in diagnosing COVID-19 pneumonia.
WHAT IT DOES
The COVID-19 Pneumonia Image Analysis Programme automatically analyses chest CT images and display findings. It features Fujifilm's picture archiving and communication system SYNAPSE...
Brisbane, Australia-based ResApp is planning to re-do its big US trial soon, but in the meantime the smartphone respiratory diagnosis company is continuing to collect data in its native country.
The company released data yesterday from a clinical study of more than 1,300 adult patients at Joondalup Health Campus in Perth and Wesley Hospital in Brisbane. While the company’s previous studies have...
ResApp, an Australian company developing an app to diagnose respiratory conditions based on cough sounds, has secured the first of three IRB approvals for its upcoming Smartcough-C pediatric trial, which will take place at the Cleveland Clinic, Massachusetts General Hospital, and a third site yet to be announced.
ResApp’s offering — an app called ResAppDx — essentially uses the smartphone...
Australia-based ResApp, a public company, has raised $9.74 million ($12.5 million Australian dollars) for its product, a smartphone-based system for diagnosing respiratory conditions. The company sold 62.5 million new ordinary shares at $0.16 ($0.20 AU) per share.
ResApp’s offering essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But instead of...
A smartphone-based system for diagnosing respiratory diseases achieved an accuracy of 89 percent in a recent clinical study of 524 pediatric patients conducted by the company at Joondalup Health Campus (JHC) and Princess Margaret Hospital (PMH) in Perth, Western Australia.
Perth-based ResApp essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But...
